Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History GNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics GNPX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Genprex Inc

GNPX
Current price
0.28 USD -0.0055 USD (-1.95%)
Last closed 0.29 USD
ISIN US3724461047
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 8 493 543 USD
Yield for 12 month -85.73 %
1Y
3Y
5Y
10Y
15Y
GNPX
21.11.2021 - 28.11.2021

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing gene-based therapies for patient populations with unmet medical needs. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which uses lipid-based nanoparticles in a lipoplex form to deliver tumor suppressor gene-expressing plasmids to cancer cells. The company's lead product candidate, Reqorsa gene therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials for the treatment of non-small cell lung cancer and small cell lung cancer. It is also developing diabetes gene therapy, a novel infusion process that uses an adeno-associated virus vector to deliver Pdx1 and MafA genes directly to the pancreas; GPX-002 for Type 1 diabetes transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. It has research agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Address: 3300 Bee Cave Road, Austin, TX, United States, 78746

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.50 USD

P/E Ratio

Dividend Yield

Financials GNPX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures GNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

+9 916 USD

Last Quarter

Current Year

Last Year

-15 004 USD

Current Quarter

Last Quarter

EBITDA -21 167 474 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -178.90 %
PEG Ratio
Return On Equity TTM -473.37 %
Wall Street Target Price 7.50 USD
Revenue TTM
Book Value 0.16 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.74 USD
Diluted Eps TTM -1.74 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation GNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.18
Price Book MRQ 2.22

Technical Indicators GNPX

For 52 Weeks

0.20 USD 3.97 USD
50 Day MA 0.28 USD
Shares Short Prior Month 2 298 383
200 Day MA 0.64 USD
Short Ratio 0.34
Shares Short 3 319 644
Short Percent 10.62 %